{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:47:26Z","timestamp":1794541646035,"version":"4.9.1"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES<\/jats:title>\n                  <jats:p>In the 2023\u20132024 respiratory syncytial virus (RSV) season, Spain became one of the first countries to introduce universal RSV prophylaxis, during which all infants born at this time were eligible to receive nirsevimab. Locally, most Spanish regions also immunized infants younger than age 6 months at the start of the season (extended catch-up). The aim of this study was to assess how RSV prophylaxis affected the number of infants presenting to pediatric emergency departments with acute respiratory infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A retrospective study was conducted in 15 Spanish pediatric emergency departments from 9 different regions between the 2018 and 2024 epidemic seasons (November\u2013January). We compared the seasons occurring in 2018\u20132023 and the 2023\u20132024 season regarding the number of episodes of lower respiratory tract infection and acute bronchiolitis, acute bronchiolitis-related hospital admissions, and PICU admissions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A comparison with the average rates for the previous epidemic seasons revealed a 57.7% decrease in episodes of lower respiratory tract infection in 2023\u20132024 (95% CI, 56.5\u201358.8; P &amp;lt; .001; range among hospitals, 4.8\u201382.8), a 59.2% decrease in episodes of acute bronchiolitis (95% CI, 57.9\u201360.4; P &amp;lt; .001; range, 6.9\u201384.1), a 63.1% reduction in acute bronchiolitis-related hospital admissions (95% CI, 60.9\u201365.2; P &amp;lt; .001; range, 31.4\u201386.8), and a 63.1% reduction in PICU admissions (95% CI, 58.1\u201367.9; P &amp;lt; .001; range, 18.2\u201381.8). Hospitals in regions applying extended catch-up showed better results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Nirsevimab can protect a broad infant population against RSV infection with high effectiveness. Approaches including extended catch-up are the most effective, although cost- effectiveness must be considered.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2024-066584","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:07:21Z","timestamp":1726042041000},"source":"Crossref","is-referenced-by-count":40,"title":["Nirsevimab and Acute Bronchiolitis Episodes in Pediatric Emergency Departments"],"prefix":"10.1542","volume":"154","author":[{"given":"David","family":"Andina Mart\u00ednez","sequence":"first","affiliation":[{"name":"aPediatric Emergency Department, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"},{"name":"bInstituto de Investigaci\u00f3n Sanitaria Hospital Universitario La Princesa, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Claret Teruel","sequence":"additional","affiliation":[{"name":"cPediatric Emergency Department, Hospital Sant Joan de D\u00e9u, Barcelona, Spain"},{"name":"dUniversity of Barcelona, Barcelona, Spain"},{"name":"eEnvironment Effects on Child\/Adolescent Well-being, Institut de Recerca Sant Joan de D\u00e9u (IRSJD), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gij\u00f3n Mediavilla","sequence":"additional","affiliation":[{"name":"fPediatric Emergency Department, Hospital Universitario Doce de Octubre. Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"C\u00e1mara Otegui","sequence":"additional","affiliation":[{"name":"gPediatric Emergency Department, Hospital Universitario Donostia, Biogipuzkoa Health Research Institute, San Sebasti\u00e1n, Spain"},{"name":"hUniversity of the Basque Country, UPV-EHU, San Sebasti\u00e1n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ba\u00f1os L\u00f3pez","sequence":"additional","affiliation":[{"name":"iPediatric Emergency Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"de Miguel Lavisier","sequence":"additional","affiliation":[{"name":"jPediatric Emergency Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ferrero Garc\u00eda-Loygorri","sequence":"additional","affiliation":[{"name":"kPediatric Emergency Department, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"S\u00e1nchez Tatay","sequence":"additional","affiliation":[{"name":"lPediatric Emergency Department, Hospital Universitario Virgen del Roc\u00edo, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Pavlovic Nesic","sequence":"additional","affiliation":[{"name":"mPediatric Emergency Department, Complejo Hospitalario Universitario Insular Materno Infantil de Canarias, Las Palmas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Clerigu\u00e9 Arrieta","sequence":"additional","affiliation":[{"name":"nPediatric Emergency Department, Hospital Universitario de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Gimeno-Hern\u00e1ndez Garza","sequence":"additional","affiliation":[{"name":"oPediatric Emergency Department, Hospital Universitario Miguel Servet de Zaragoza, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Lorenzo","family":"Guerra Diez","sequence":"additional","affiliation":[{"name":"pPediatric Emergency Department, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Ranera M\u00e1laga","sequence":"additional","affiliation":[{"name":"qPediatric Emergency Department, Corporacio Sanitaria Parc Tauli, Institut d\u2032Investigaci\u00f3 e innovacio, I3PT; Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Escalada Pellitero","sequence":"additional","affiliation":[{"name":"rPediatric Emergency Department, Hospital Universitario de Canarias, Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Barrueco Ramos","sequence":"additional","affiliation":[{"name":"sPediatric Emergency Department, Complexo Hospitalario Universitario de A Coru\u00f1a, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Alonso-Cadenas","sequence":"additional","affiliation":[{"name":"aPediatric Emergency Department, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"},{"name":"bInstituto de Investigaci\u00f3n Sanitaria Hospital Universitario La Princesa, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Impact of universal Respiratory Syncytial Virus prophylaxis in Spain Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"3","key":"2024100102520611000_B1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/INF.0000000000000993","article-title":"Population-based analysis of bronchiolitis epidemiology in Valencia, Spain","volume":"35","author":"Mu\u00f1oz-Quiles","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2024100102520611000_B2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1185\/03007995.2015.1136606","article-title":"Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004\u20132012","volume":"32","author":"Sanchez-Luna","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2024100102520611000_B3","doi-asserted-by":"crossref","first-page":"e20192614","DOI":"10.1542\/peds.2019-2614","article-title":"Trends in bronchiolitis hospitalizations in the United States: 2000\u20132016","volume":"144","author":"Fujiogi","year":"2019","journal-title":"Pediatrics"},{"key":"2024100102520611000_B4","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1093\/cid\/ciab528","article-title":"Global respiratory syncytial virus\u2013related infant community deaths","volume":"73","author":"Mazur","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2024100102520611000_B5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/INF.0b013e31829b7e43","article-title":"Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years","volume":"32","author":"Miller","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2024100102520611000_B6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40121-020-00390-7","article-title":"Socioeconomic impact of RSV hospitalization","volume":"10","author":"Young","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"1","key":"2024100102520611000_B7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12879-021-06629-z","article-title":"The impact of childhood RSV infection on children\u2019s and parents\u2019 quality of life: a prospective multicenter study in Spain","volume":"21","author":"D\u00edez-Gand\u00eda","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2024100102520611000_B8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12879-014-0544-x","article-title":"Social, economic, and health impact of the respiratory syncytial virus: a systematic search","volume":"14","author":"Diez-Domingo","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"2024100102520611000_B9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.anpedi.2019.08.003","article-title":"An update of the recommendations of the Spanish Neonatology Society for the use of palivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants","volume":"91","author":"S\u00e1nchez Luna","year":"2019","journal-title":"An Pediatr (Engl Ed)"},{"key":"2024100102520611000_B10","unstructured":"AstraZeneca\u2008AB\n          . Summary of product characteristics: Beyfortus 50 mg\/100 mg solution for injection. 2022 Available at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/beyfortus-epar-product-information_en.pdf. Accessed March 10, 2023"},{"issue":"16","key":"2024100102520611000_B11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for prevention of RSV in term and late-preterm infants","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med"},{"issue":"26","key":"2024100102520611000_B12","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for prevention of hospitalizations due to RSV in infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N Engl J Med"},{"key":"2024100102520611000_B13","unstructured":"Spanish Ministry of Health. Presentation of the Immunization Program and Registry. Recommendations for the use of nirsevimab against respiratory syncytial virus for the 2023\u20132024 season. 2023. Available at: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/Nirsevimab.pdf. Accessed March 10, 2023"},{"issue":"41","key":"2024100102520611000_B14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2024100102520611000_B15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ppul.23750","article-title":"The heterogeneity of viral bronchiolitis: a lack of universal consensus definitions","volume":"52","author":"Hancock","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"2024100102520611000_B16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eimc.2014.12.012","article-title":"Monitoring respiratory syncytial virus through the Spanish influenza surveillance system, 2006\u20132014","volume":"34","author":"Jim\u00e9nez-Jorge","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"2024100102520611000_B17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(23)00630-8","article-title":"Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis","volume":"24","author":"Cong","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2024100102520611000_B18","doi-asserted-by":"crossref","first-page":"2400033","DOI":"10.2807\/1560-7917.ES.2024.29.4.2400033","article-title":"Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023\/24 season in Luxembourg","volume":"29","author":"Ernst","year":"2024","journal-title":"Euro Surveill"},{"issue":"6","key":"2024100102520611000_B19","doi-asserted-by":"crossref","first-page":"2400046","DOI":"10.2807\/1560-7917.ES.2024.29.6.2400046","article-title":"Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024","volume":"29","author":"L\u00f3pez-Lacort","year":"2024","journal-title":"Euro Surveill"},{"issue":"49","key":"2024100102520611000_B20","doi-asserted-by":"crossref","first-page":"2300606","DOI":"10.2807\/1560-7917.ES.2023.28.49.2300606","article-title":"Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023","volume":"28","author":"Martin\u00f3n-Torres","year":"2023","journal-title":"Euro Surveill"},{"issue":"5","key":"2024100102520611000_B21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.anpedi.2016.10.002","article-title":"Epidemiology of patients hospitalised due to bronchiolitis in the south of Europe: analysis of the epidemics, 2010\u20132015","volume":"87","author":"Ramos-Fern\u00e1ndez","year":"2017","journal-title":"An Pediatr (Barc)"},{"key":"2024100102520611000_B22","unstructured":"Regional Health Ministry. Technical document on immunization against respiratory syncytial virus in infants in the community of Madrid in the 2023\u20132024 season. 2023. Available at: https:\/\/www.comunidad.madrid\/sites\/default\/files\/doc\/sanidad\/prev\/documento_tecnico_inmunizacion_vrs.pdf. Accessed March 10, 2023"},{"issue":"34","key":"2024100102520611000_B23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices - United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024100102520611000_B24","first-page":"100629","article-title":"Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: a simulation study","volume":"28","author":"Shoukat","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"2024100102520611000_B25","unstructured":"Bernardo\u2008A, Civio\u2008F. The public health system pays 209 euros for each childhood vaccination against bronchiolitis. CIVIO: Medicamentalia. 2023. Available at: https:\/\/civio.es\/medicamentalia\/2023\/10\/30\/nirsevimab-beyfortus-precio-virus-respiratorio-sincitial\/. Accessed March 10, 2023"},{"issue":"11","key":"2024100102520611000_B26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41579-023-00919-w","article-title":"Respiratory syncytial virus infection and novel interventions","volume":"21","author":"Langedijk","year":"2023","journal-title":"Nat Rev Microbiol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-066584\/1717424\/peds.2024-066584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-066584\/1717424\/peds.2024-066584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T02:52:25Z","timestamp":1727751145000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/154\/4\/e2024066584\/199339\/Nirsevimab-and-Acute-Bronchiolitis-Episodes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,11]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2024-066584","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"article-number":"e2024066584"}}